rx 821002 has been researched along with Carcinoma, Hepatocellular in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cayla, C; Gales, C; Paris, H; Quinchon, F; Roquelaine, C; Schaak, S | 1 |
1 other study(ies) available for rx 821002 and Carcinoma, Hepatocellular
| Article | Year |
|---|---|
Homologous regulation of the alpha2C-adrenoceptor subtype in human hepatocarcinoma, HepG2.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Binding, Competitive; Brimonidine Tartrate; Carcinoma, Hepatocellular; Humans; Idazoxan; Quinolizines; Quinoxalines; Receptors, Adrenergic, alpha-2; RNA, Messenger; Tritium; Tumor Cells, Cultured | 1999 |